Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1618 1643 1647 1681 1682 1797
This examiner grants 81% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18561673 | JAK Inhibitors for Managing Conditions in Patients with Down's Syndrome or Other Trisomy | Non-Final OA | Emory University |
| 18559009 | Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18481673 | RECOMBINANT LIGASE COMPOSITION AND USES THEREOF | Non-Final OA | 10x Genomics, Inc. |
| 18289674 | SINGLE CHAIN TRIMER MHC CLASS I NUCLEIC ACIDS AND PROTEINS AND METHODS OF USE | Non-Final OA | California Institute of Technology |
| 18544247 | GENE THERAPY TREATMENT OF ATRIAL FIBRILLATION | Non-Final OA | Northwestern University |
| 18583340 | Compositions and Methods for Targeting Connexin Hemichannels | Non-Final OA | Board of Regents, The University of Texas System |
| 18555214 | METHODS TO DETERMINE TREATMENT EFFICACY WITH GAMMA-DELTA T CELLS | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18682707 | COMPOSITIONS AND METHODS FOR ENHANCING BRAIN PERFUSION | Non-Final OA | Washington University |
| 18276700 | EPITOPE PEPTIDE AND ANTIBODY FOR PREVENTING AND TREATING EB VIRUS INFECTION AND RELATED DISEASES | Non-Final OA | SUN YAT-SEN UNIVERSITY |
| 18682713 | CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING gD AND ONCOLYTIC VIRUSES FOR CANCER THERAPY AND TREATMENT OF HSV | Non-Final OA | City of Hope |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy